Ischemic Stroke Clinical Trial
Official title:
Motor Task Performance Under Visual and Auditory Feedback Post Stroke: a Randomized Crossover Trial
Verified date | June 2017 |
Source | Sword Health, SA |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
The study was designed to evaluate the impact of a novel kinematic biofeedback system -
SWORD - in the motor performance of patients after stroke. The SWORD system combines
inertial motion trackers and a mobile app, allowing digitization of patient motion and
providing real-time audiovisual biofeedback.
The investigators hypothesize that the biofeedback feedback provided by the SWORD system
improves patient performance, defined as an increase in the number of correct movements.
The design of the study is a cross-over randomized clinical trial. Patients will be
randomized into two groups. Both will perform two separate sessions consisting of one
exercise - shoulder flexion with elbow flexion at 90 degrees - for 4 minutes in both
experimental settings: with and without biofeedback. Group 1 will perform the exercise with
biofeedback first and without biofeedback after, with an interval >24h. Group 2 will perform
the exercise in the opposite order. The SWORD system will be used to record movement data in
both sessions, but the feedback was only active in one of them.
Status | Completed |
Enrollment | 30 |
Est. completion date | August 31, 2016 |
Est. primary completion date | August 31, 2016 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years and older |
Eligibility |
Inclusion Criteria: - clinical symptoms and signs and CT or MRI findings compatible with a lesion in the territory of the medial cerebral artery; - persistent motor deficit on the upper limb but not plegia with a score between 0 and 2 on item 5b of the National Institute of Health Stroke Scale (NIHSS) - more than 2 weeks after stroke onset; - the ability to sit comfortably for more than 10 minutes and perform two-step commands Exclusion Criteria: - no detectable motor deficits at baseline assessment; - severe aphasia; - clinical dementia or mini mental state examination (MMSE) below cutoff; - other cognitive or psychiatric comorbidity that impaired communication or compliance with the tasks; - severe respiratory or cardiac condition incompatible with more than 5 minutes of continuous mild exercise in a sitting position; - pain or deformity that limited upper limb movement on the affected side. |
Country | Name | City | State |
---|---|---|---|
Portugal | CMM - Centro Médico de Aveiro | Aveiro | |
Portugal | CMM - Murtosa | Murtosa | Aveiro |
Portugal | CMM- Centro Médico de Viseu | Viseu |
Lead Sponsor | Collaborator |
---|---|
Sword Health, SA | Centro Médico de Viseu, CMM - Centro Médico da Murtosa, CMM - Centro Médico de Aveiro |
Portugal,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Number of correct movements | Number of correct movements performed within the duration of each exercise session | At the end of each exercise session (4 minute duration) | |
Secondary | Total number of repetitions | Total number of repetitions performed within the duration of each exercise session | At the end of each exercise session (4 minute duration) | |
Secondary | Number of incorrect repetitions | Number of incorrect repetitions performed within the duration of each exercise session | At the end of each exercise session (4 minute duration) | |
Secondary | Number of consecutive incorrect repetitions | Number of consecutive incorrect repetitions performed within the duration of each exercise session | At the end of each exercise session (4 minute duration) | |
Secondary | Number of pauses | Number of pauses registered during each exercise session | At the end of each exercise session (4 minute duration) | |
Secondary | Posture errors | Number of posture errors registered during each exercise session | At the end of each exercise session (4 minute duration) | |
Secondary | Movement frequency | Movement frequency (in Hertz) during each exercise session | At the end of each exercise session (4 minute duration) | |
Secondary | Range of motion of correct movements | Mean range of motion of the correct movements performed during each exercise session | At the end of each exercise session (4 minute duration) | |
Secondary | Range of motion variability over time | Variability of the mean range of motion during the exercise session (for correct movements) | Between the second and first minute; between the second and third minutes; between the third and fourth minute |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT05196659 -
Collaborative Quality Improvement (C-QIP) Study
|
N/A | |
Recruiting |
NCT06027788 -
CTSN Embolic Protection Trial
|
N/A | |
Completed |
NCT03281590 -
Stroke and Cerebrovascular Diseases Registry
|
||
Recruiting |
NCT05518305 -
Platelet Expression of FcγRIIa and Arterial Hemodynamics to Predict Recurrent Stroke in Intracranial Atherosclerosis
|
||
Recruiting |
NCT06029959 -
Stroke and CPAP Outcome Study 3
|
N/A | |
Recruiting |
NCT03728738 -
Zero Degree Head Positioning in Hyperacute Large Artery Ischemic Stroke
|
Phase 3 | |
Terminated |
NCT03396419 -
IMPACT- 24col Collateral Blood Flow Assessment Following SPG Stimulation in Acute Ischemic Stroke (ImpACT-24B Sub-Study)
|
||
Recruiting |
NCT05065216 -
Treatment of Acute Ischemic Stroke (ReMEDy2 Trial)
|
Phase 2/Phase 3 | |
Recruiting |
NCT04897334 -
Transcranial Direct Current Stimulation and Rehabilitation to Ameliorate Impairments in Neurocognition After Stroke
|
N/A | |
Not yet recruiting |
NCT06462599 -
Osteopontin Gene Polymorphism in Stroke Patients in Egypt
|
||
Not yet recruiting |
NCT06026696 -
Cohort of Neurovascular Diseases Treated in the Acute Phase and Followed at Lariboisière
|
||
Not yet recruiting |
NCT06032819 -
Differentiating Between Brain Hemorrhage and Contrast
|
||
Recruiting |
NCT02910180 -
Genetic, Metabolic, and Growth Factor Repository for Cerebrovascular Disorders
|
||
Completed |
NCT02922452 -
A Study to Evaluate the Effect of Diltiazem on the Pharmacokinetics (PK) of BMS-986141 in Healthy Subjects
|
Phase 1 | |
Withdrawn |
NCT01866189 -
Identification of Hypoxic Brain Tissues by F-MISO PET in Acute Ischemic Stroke
|
N/A | |
Completed |
NCT03554642 -
Walkbot Robotic Training for Improvement in Gait
|
Phase 3 | |
Recruiting |
NCT03041753 -
Reperfusion Injury After Stroke Study
|
N/A | |
Completed |
NCT02549846 -
AdminiStration of Statin On Acute Ischemic stRoke patienT Trial
|
Phase 4 | |
Completed |
NCT01678534 -
Reparative Therapy in Acute Ischemic Stroke With Allogenic Mesenchymal Stem Cells From Adipose Tissue, Safety Assessment, a Randomised, Double Blind Placebo Controlled Single Center Pilot Clinical Trial
|
Phase 2 | |
Completed |
NCT02610803 -
Paroxysmal Atrial Fibrillation in Patients With Acute Ischemic Stroke
|
N/A |